Full Breakdown
Trump Administration Seeks Supreme Court Relief to Enforce New Transgender Inmate Care Restrictions
By Drooid · · How we work
Supreme Court Emergency Request
On September 28, the Justice Department filed an emergency application asking the United States Supreme Court to lift a district-court injunction that blocks a February 2026 Bureau of Prisons (BOP) policy. The policy would prohibit hormone therapy, gender-affirming surgeries, and “social accommodations” such as wigs, chest binders, and hair-removal devices for inmates diagnosed with gender dysphoria, while retaining access to psychiatric and psychotherapy services. The request follows a September 18 decision by the U.S. Court of Appeals for the District of Columbia Circuit that refused to suspend the injunction.
Background & Context
The order required the BOP to revise its medical-care policies, resulting in the February 2026 directive that bars new hormone interventions, surgeries, and gender-related accommodations, and calls for tapering hormones already prescribed.
Three transgender inmates—one each in federal facilities in New Jersey, Florida, and Minnesota—filed a class-action lawsuit in 2025 challenging the restrictions as a denial of medically necessary care. U.S. District Judge Royce Lamberth, a Reagan appointee, issued a preliminary injunction in June, finding the policy likely “arbitrary and capricious” under the Administrative Procedure Act because the BOP ignored its own prior experience providing gender-affirming care.
Data & Statistics
- The BOP reported in 2025 that more than 600 inmates were receiving hormone-therapy treatment.
- The class-action suit represents three transgender inmates currently incarcerated in federal prisons.
Official Statements & Responses
- John D. Sauer, Solicitor General of the United States, argued that the BOP “reasonably considered its prior experience” and concluded that the disputed interventions are “medically unnecessary” and that security and prison-administration concerns justify the policy.
Criticism & Opposition
Legal analysts and civil-rights groups have highlighted that the policy reverses a previously established practice of providing gender-affirming treatment when clinicians deemed it medically appropriate. Critics note that the D.C. Circuit panel questioned the BOP’s reliance on “security” rationales, observing that the agency offered no evidence of actual security incidents linked to gender-affirming care.
Verbatim Quotes
- “With this opinion, the court has no intention of wading into the culture war being waged against transgender individuals,” — Royce Lamberth, US district judge
- “Tellingly, while the court of appeals asserted otherwise, it provided no explanation to support that assertion,” — General D. John Sauer
Conflicting Reports & Gaps
No source provides a differing figure for the number of inmates receiving hormone therapy; all cite the BOP’s statement of “more than 600.” No additional quantitative data on the prevalence of gender-affirming accommodations in federal prisons is offered, leaving the scope of the policy’s impact beyond the named plaintiffs unclear.
What’s Next
The Supreme Court is expected to rule on the emergency request within a few weeks. The court has ordered the plaintiffs to file a response by October 8, a scheduled deadline. A decision will determine whether the BOP may enforce the restrictions while the underlying litigation proceeds.